Descripción del proyecto
Tratamiento multimodal para mejorar el estado funcional de personas mayores con diabetes
En el proyecto DIABFRAIL-LATAM, financiado con fondos europeos, se reúne un equipo multidisciplinar de personal académico, investigadores y profesionales sanitarios para mejorar la calidad de vida y el estado funcional de las personas mayores con diabetes. La diabetes, cuya prevalencia es elevada en las poblaciones de edad avanzada, se asociada con comorbilidad médica, pérdida y fragilidad funcional, y la discapacidad visual y de las extremidades inferiores. El proyecto se basará en los resultados de tres proyectos financiados con fondos europeos (MIDFRAIL, FRAILOMIC y VIVIFRAIL) para ampliar un tratamiento multimodal entre las personas mayores con diabetes en cuatro países latinoamericanos (Chile, Colombia, México y Perú). Tras su validación, DIABFRAIL-LATAM se extenderá a otros países de América Latina y el Caribe. El tratamiento incluye programas de ejercicio y formación. Su éxito se medirá en función de los cambios logrados en la función física y la calidad de vida.
Objetivo
Stemming from the results of three EU-funded projects, DIABFRAIL-LATAM intends to make a scaling up of a multimodal intervention in older people with diabetes very vulnerable because of their frailty status. The scaling up will take place in 5 Latin-American countries (1 HIC and 4 LMICs), in different settings of care. The project embraces three main parts: 1) a validation study (an open Randomized Clinical Trial) that mimics the intervention to be transferred and that was shown to be effective and with a good cost-effective relationship; 2) a feasibility study that will include an economic analysis, adherence assessment and an analysis of the barriers and key factor of success; and 3) a proper scaling up process using a methodology based on the recommendations of the WHO (“WHO ExpandNet model”) and the European Union (“Maturity Model” and “11 success factors” suggested by the Expert Group on Health Systems Performance Assessment) that will take place not only in the five countries participating in the validation of the intervention, but also in other four countries, under the auspices of the Pan-American Health Organization and the cooperation of the local governments.
The consortium of the project is composed by a multidisciplinary team of partners involving academic partners, research partners, clinical partners, public health partners and citizen organizations. In addition, several local, national and international stakeholders, including governmental organizations and NGOs will also provide support in the several settings of care.
The project is clearly aligned with the programs of many of the institutions constituting the Global Alliance for Chronic Diseases (GACD), including the Research&Innovation DG of the European Commission, with projects supported by GACD, with several actions of the EIP-AHA initiative and with strategies on non-communicable chronic conditions in the EU, in several countries of the Latin-American and Caribbean Region, PAHO and WHO.
Ámbito científico
Palabras clave
Programa(s)
Convocatoria de propuestas
Consulte otros proyectos de esta convocatoriaConvocatoria de subcontratación
H2020-SC1-2018-Single-Stage-RTD
Régimen de financiación
RIA - Research and Innovation actionCoordinador
28029 Madrid
España